InspireMD, Inc. (NYSE: NSPR) was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes. Today, InspireMD is a global company headquartered in Boston, Massachusetts, seeking to utilize its proprietary MicroNet technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures. For more information, visit the company’s website at www.inspire-md.com.